Fps/Fes and Fer protein-tyrosine kinases play redundant roles in regulating hematopoiesis

Experimental Hematology

Volumn 31, Issue 8, 2003, Pages 673-681

  Senis, Yotis A ^a,c   Craig, Andrew W B ^a   Greer, Peter A ^a,b  

^a QUEEN S UNIVERSITY   (Canada)

^b QUEEN S UNIVERSITY   (Canada)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ISOENZYME; PROTEIN TYROSINE KINASE;

ALLELE; ANALYTIC METHOD; ANIMAL EXPERIMENT; ARTICLE; BLOOD CELL COUNT; BONE MARROW CELL; BREEDING; CELL ADHESION; COLONY FORMING UNIT; CONTROLLED STUDY; ENZYME ACTIVITY; ERYTHROCYTE COUNT; FERTILITY; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HOMOZYGOSITY; MUTATION; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROGENY; QUALITATIVE ANALYSIS; REGULATORY MECHANISM; THROMBOCYTE COUNT; WILD TYPE;

EID: 0042668364     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(03)00107-3     Document Type: Article

References (54)

1. Alcalay M., Antolini F., Van de Ven W.J., Lanfrancone L., Grignani F., Pelicci P.G. Characterization of human and mouse c-fes cDNA clones and identification of the 5′ end of the gene. Oncogene. 5:1990;267-275.
2. Feldman R.A., Gabrilove J.L., Tam J.P., Moore M.A., Hanafusa H. Specific expression of the human cellular fps/fes-encoded protein NCP92 in normal and leukemic myeloid cells. Proc Natl Acad Sci USA. 82:1985;2379-2383.
3. Greer P., Maltby V., Rossant J., Bernstein A., Pawson T. Myeloid expression of the human c-fps/fes proto-oncogene in transgenic mice. Mol Cell Biol. 10:1990;2521-2527.
4. MacDonald I., Levy J., Pawson T. Expression of the mammalian c-fes protein in hematopoietic cells and identification of a distinct fes-related protein. Mol Cell Biol. 5:1985;2543-2551.
5. Wilks A.F., Kurban R.R. Isolation and structural analysis of murine c-fes cDNA clones. Oncogene. 3:1988;289-294.
6. Haigh J., McVeigh J., Greer P. The fps/fes tyrosine kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells and is localized in the trans-golgi network. Cell Growth Differ. 7:1996;931-944.
7. Hanazono Y., Chiba S., Sasaki K., Mano H., Yazaki Y., Hirai H. Erythropoietin induces tyrosine phosphorylation and kinase activity of the c-fps/fes proto-oncogene product in human erythropoietin-responsive cells. Blood. 81:1993;3193-3196.
8. Hanazono Y., Chiba S., Sasaki K., et al. c-fps/fes protein-tyrosine kinase is implicated in a signaling pathway triggered by granulocyte-macrophage colony-stimulating factor and interleukin-3. EMBO J. 12:1993;1641-1646.
9. Izuhara K., Feldman R.A., Greer P., Harada N. Interaction of the c-fes proto-oncogene product with the interleukin-4 receptor. J Biol Chem. 269:1994;18623-18629.
10. Kirito K., Nakajima K., Watanabe T., et al. Identification of the human erythropoietin receptor region required for Stat1 and Stat3 activation. Blood. 99:2002;102-110.
11. Linnekin D., Mou S.M., Greer P., Longo D.L., Ferris D.K. Phosphorylation of a Fes-related protein in response to granulocyte-macrophage colony stimulating factor. J Biol Chem. 270:1995;4950-4954.
12. Matsuda T., Fukada T., Takahashi-Tezuka M., et al. Activation of Fes tyrosine kinase by gp130, an interleukin-6 family cytokine signal transducer, and their association. J Biol Chem. 270:1995;11037-11039.
13. Hao Q.L., Heisterkamp N., Groffen J. Isolation and sequence analysis of a novel human tyrosine kinase gene. Mol Cell Biol. 9:1989;1587-1593.
14. Letwin K., Yee S.P., Pawson T. Novel protein-tyrosine kinase cDNAs related to fps/fes and eph cloned using anti-phosphotyrosine antibody. Oncogene. 3:1988;621-627.
15. Pawson T., Letwin K., Lee T., Hao Q.L., Heisterkamp N., Groffen J. The FER gene is evolutionarily conserved and encodes a widely expressed member of the FPS/FES protein-tyrosine kinase family. Mol Cell Biol. 9:1989;5722-5725.
16. Craig A.W., Zirngibl R., Greer P. Disruption of coiled-coil domains in Fer protein-tyrosine kinase abolishes trimerization but not kinase activation. J Biol Chem. 274:1999;19934-19942.
17. Aspenstrom P. A Cdc42 target protein with homology to the non-kinase domain of FER has a potential role in regulating the actin cytoskeleton. Curr Biol. 7:1997;479-487.
18. Greer P. Closing in on the biological functions of Fps/Fes and Fer. Nature Reviews Molecular Cell Biology. 3:2002;278-289.
19. Linder S., Hufner K., Wintergerst U., Aepfelbacher M. Microtubule-dependent formation of podosomal adhesion structures in primary human macrophages. J Cell Sci. 113 Pt 23:2000;4165-4176.
20. Kim L., Wong T.W. The cytoplasmic tyrosine kinase FER is associated with the catenin-like substrate pp120 and is activated by growth factors. Mol Cell Biol. 15:1995;4553-4561.
21. Read R.D., Lionberger J.M., Smithgall T.E. Oligomerization of the Fes tyrosine kinase. Evidence for a coiled-coil domain in the unique N-terminal region. J Biol Chem. 272:1997;18498-18503.
22. Cheng H., Rogers J.A., Dunham N.A., Smithgall T.E. Regulation of c-Fes tyrosine kinase and biological activities by N-terminal coiled-coil oligomerization domains. Mol Cell Biol. 19:1999;8335-8343.
23. Cheng H.Y., Schiavone A.P., Smithgall T.E. A point mutation in the N-terminal coiled-coil domain releases c-Fes tyrosine kinase activity and survival signaling in myeloid leukemia cells. Mol Cell Biol. 21:2001;6170-6180.
24. Hjermstad S.J., Peters K.L., Briggs S.D., Glazer R.I., Smithgall T.E. Regulation of the human c-fes protein tyrosine kinase (p93c-fes) by its src homology 2 domain and major autophosphorylation site (Tyr-713). Oncogene. 8:1993;2283-2292.
25. Rogers J.A., Cheng H.Y., Smithgall T.E. Src homology 2 domain substitution modulates the kinase and transforming activities of the Fes protein-tyrosine kinase. Cell Growth Differ. 11:2000;581-592.
26. Penhallow R.C., Class K., Sonoda H., Bolen J.B., Rowley R.B. Temporal activation of nontransmembrane protein-tyrosine kinases following mast cell FcεRI engagement. J Biol Chem. 270:1995;23362-23365.
27. Craig A.W., Zirngibl R., Williams K., Cole L.A., Greer P.A. Mice devoid of fer protein-tyrosine kinase activity are viable and fertile but display reduced cortactin phosphorylation. Mol Cell Biol. 21:2001;603-613.
28. Arregui C., Pathre P., Lilien J., Balsamo J. The nonreceptor tyrosine kinase fer mediates cross-talk between N-cadherin and β1-integrins. J Cell Biol. 149:2000;1263-1274.
29. Li H., Leung T.C., Hoffman S., Balsamo J., Lilien J. Coordinate regulation of cadherin and integrin function by the chondroitin sulfate proteoglycan neurocan. J Cell Biol. 149:2000;1275-1288.
30. Kim L., Wong T.W. Growth factor-dependent phosphorylation of the actin-binding protein cortactin is mediated by the cytoplasmic tyrosine kinase FER. J Biol Chem. 273:1998;23542-23548.
31. Kapus A., Di Ciano C., Sun J., et al. Cell volume-dependent phosphorylation of proteins of the cortical cytoskeleton and cell-cell contact sites. The role of Fyn and FER kinases. J Biol Chem. 275:2000;32289-32298.
32. Priel-Halachmi S., Ben-Dor I., Shpungin S., et al. FER kinase activation of Stat3 is determined by the N-terminal sequence. J Biol Chem. 275:2000;28902-28910.
33. Orlovsky K., Theodor L., Malovani H., Chowers Y., Nir U. γ-interferon down-regulates Fer and induces its association with inactive Stat3 in colon carcinoma cells. Oncogene. 21:2002;4997-5001.
34. Senis Y., Zirngibl R., McVeigh J., Haman A., Hoang T., Greer P.A. Targeted disruption of the murine fps/fes proto-oncogene reveals that Fps/Fes kinase activity is dispensable for hematopoiesis. Mol Cell Biol. 19:1999;7436-7446.
35. -/-mice. Immunity. 13:2000;397-407.
36. Zirngibl R.A., Senis Y., Greer P.A. Enhanced endotoxin sensitivity in fps/fes-null mice with minimal defects in hematopoietic homeostasis. Mol Cell Biol. 22:2002;2472-2486.
37. Cole L.A., Zirngibl R., Craig A.W., Jia Z., Greer P. Mutation of a highly conserved aspartate residue in subdomain IX abolishes Fer protein-tyrosine kinase activity. Protein Eng. 12:1999;155-162.
38. Aardal N.P., Laerum O.D. Circadian variations in mouse bone marrow. Exp Hematol. 11:1983;792-801.
39. Craig A.W., Greer P.A. Fer kinase is required for sustained p38 kinase activation and maximal chemotaxis of activated mast cells. Mol Cell Biol. 22:2002;6363-6374.
40. McCafferty D.M., Craig A.W., Senis Y.A., Greer P.A. Absence of Fer protein-tyrosine kinase exacerbates leukocyte recruitment in response to endotoxin. J Immunol. 168:2002;4930-4935.
41. Smithgall T.E., Yu G., Glazer R.I. Identification of the differentiation-associated p93 tyrosine protein kinase of HL-60 leukemia cells as the product of the human c-fes locus and its expression in myelomonocytic cells. J Biol Chem. 263:1988;15050-15055.
42. Brizzi M.F., Aronica M.G., Rosso A., Bagnara G.P., Yarden Y., Pegoraro L. Granulocyte-macrophage colony-stimulating factor stimulates JAK2 signaling pathway and rapidly activates p93fes, STAT1 p91, and STAT3 p92 in polymorphonuclear leukocytes. J Biol Chem. 271:1996;3562-3567.
43. Park W.Y., Ahn J.H., Feldman R.A., Seo J.S. c-Fes tyrosine kinase binds to and activates STAT3 after granulocyte-macrophage colony-stimulating factor stimulation. Cancer Lett. 129:1998;29-37.
44. Yam L.T., Li C.Y., Crosby W.H. Cytochemical identification of monocytes and granulocytes. Am J Clin Pathol. 55:1971;283-290.
45. Walkley C.R., Yuan Y.D., Chandraratna R.A., McArthur G.A. Retinoic acid receptor antagonism in vivo expands the numbers of precursor cells during granulopoiesis. Leukemia. 16:2002;1763-1772.
46. Kim J., Ogata Y., Feldman R.A. Fes tyrosine kinase promotes survival and terminal granulocyte differentiation of factor-dependent myeloid progenitors (32D) and activates lineage-specific transcription factors. J Biol Chem. 278:2003;14978-14984.
47. Kim J., Feldman R.A. Activated Fes protein tyrosine kinase induces terminal macrophage differentiation of myeloid progenitors (U937 cells) and activation of the transcription factor PU.1. Mol Cell Biol. 22:2002;1903-1918.
48. McKercher S.R., Torbett B.E., Anderson K.L., et al. Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities. EMBO J. 15:1996;5647-5658.
49. Scott E.W., Simon M.C., Anastasi J., Singh H. Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science. 265:1994;1573-1577.
50. Avalos B.R. Molecular analysis of the granulocyte colony-stimulating factor receptor. Blood. 88:1996;761-777.
51. McLemore M.L., Grewal S., Liu F., et al. STAT-3 activation is required for normal G-CSF-dependent proliferation and granulocytic differentiation. Immunity. 14:2001;193-204.
52. Songyang Z., Shoelson S.E., Chaudhuri M., et al. SH2 domains recognize specific phosphopeptide sequences. Cell. 72:1993;767-778.
53. Songyang Z., Shoelson S.E., McGlade J., et al. Specific motifs recognized by the SH2 domains of Csk, 3BP2, fps/fes, GRB-2, HCP, SHC, Syk, and Vav. Mol Cell Biol. 14:1994;2777-2785.
54. Senis Y.A., Sangrar W., Zirngibl R.A., Craig A.W.B., Lee D.H., Greer P.A. Fps/Fes and Fer nonreceptor protein-tyrosine kinases regulate collagen- and ADP-induced platelet qggregation. Thrombosis and Hemostasis. 2003;. (in press).